Cargando…
HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma
Human endogenous retroviruses (HERV) and related elements account for more than 8% of the human genome and significantly contribute to the human transcriptome by long terminal repeat (LTR) promoter activity. In this context, HERVs are thought to intervene in the expression of adjacent genes by provi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492278/ https://www.ncbi.nlm.nih.gov/pubmed/23145155 http://dx.doi.org/10.1371/journal.pone.0049341 |
_version_ | 1782249098662903808 |
---|---|
author | Gosenca, Darko Gabriel, Ute Steidler, Annette Mayer, Jens Diem, Olivia Erben, Philipp Fabarius, Alice Leib-Mösch, Christine Hofmann, Wolf-Karsten Seifarth, Wolfgang |
author_facet | Gosenca, Darko Gabriel, Ute Steidler, Annette Mayer, Jens Diem, Olivia Erben, Philipp Fabarius, Alice Leib-Mösch, Christine Hofmann, Wolf-Karsten Seifarth, Wolfgang |
author_sort | Gosenca, Darko |
collection | PubMed |
description | Human endogenous retroviruses (HERV) and related elements account for more than 8% of the human genome and significantly contribute to the human transcriptome by long terminal repeat (LTR) promoter activity. In this context, HERVs are thought to intervene in the expression of adjacent genes by providing regulatory sequences (cis-effect) or via noncoding RNA including natural antisense transcripts. To address the potential impact of HERV activity in urothelial carcinoma, we comparatively analyzed the HERV transcription profiles in paired samples of non-malignant urothelium and urothelial carcinoma derived from 13 patients with bladder cancer by means of a retrovirus-specific microarray (RetroArray). We established a characteristic HERV signature consisting of six ubiquitously active HERV subgroups (E4-1, HERV-Rb, ERV9, HERV-K-T47D, NMWV3, HERV-KC4). The transcription pattern is largely identical in human urothelial carcinoma, non-malignant urothelial tissue, four tumor-derived cell lines and in a non-malignant urothelial cell line (UROtsa). Quantitative reverse transcriptase PCR (qRT-PCR) of HERV-E4-1, HERV-K(HML-6) and HERV-T(S71-TK1) revealed a bias to lower HERV activity in carcinoma samples compared to non-malignant tissue. Determination of active HERV-E4-1 loci by cloning and sequencing revealed six HERV-E4-1 proviral loci that are differentially regulated in urothelial carcinoma cells and normal tissue. Two full-length HERV-E4-1 proviruses, HERV-Ec1 and HERV-Ec6, are located in antisense orientation in introns of the genes PLA2G4A and RNGTT, respectively. PLA2G4A encodes a cytosolic phospholipase A2 (cPLA2) that is dysregulated in many human tumors. PLA2G4A and HERV-Ec1 displayed reciprocal transcript levels in 7 of 11 urothelial carcinoma patients. Moreover, reciprocal shifts were observed after treatment of UROtsa cells with HERV-Ec1 and PLA2G4A-directed siRNAs or 5-aza-2′-deoxycytidine (aza-dC) pointing to an antagonistic regulation of PLA2G4A and HERV-Ec1 transcription in human urothelial cells. We suggest that transcription of HERV-Ec1 contributes to fine tuning of cPLA2 expression, thereby facilitating tumorigenesis. |
format | Online Article Text |
id | pubmed-3492278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34922782012-11-09 HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma Gosenca, Darko Gabriel, Ute Steidler, Annette Mayer, Jens Diem, Olivia Erben, Philipp Fabarius, Alice Leib-Mösch, Christine Hofmann, Wolf-Karsten Seifarth, Wolfgang PLoS One Research Article Human endogenous retroviruses (HERV) and related elements account for more than 8% of the human genome and significantly contribute to the human transcriptome by long terminal repeat (LTR) promoter activity. In this context, HERVs are thought to intervene in the expression of adjacent genes by providing regulatory sequences (cis-effect) or via noncoding RNA including natural antisense transcripts. To address the potential impact of HERV activity in urothelial carcinoma, we comparatively analyzed the HERV transcription profiles in paired samples of non-malignant urothelium and urothelial carcinoma derived from 13 patients with bladder cancer by means of a retrovirus-specific microarray (RetroArray). We established a characteristic HERV signature consisting of six ubiquitously active HERV subgroups (E4-1, HERV-Rb, ERV9, HERV-K-T47D, NMWV3, HERV-KC4). The transcription pattern is largely identical in human urothelial carcinoma, non-malignant urothelial tissue, four tumor-derived cell lines and in a non-malignant urothelial cell line (UROtsa). Quantitative reverse transcriptase PCR (qRT-PCR) of HERV-E4-1, HERV-K(HML-6) and HERV-T(S71-TK1) revealed a bias to lower HERV activity in carcinoma samples compared to non-malignant tissue. Determination of active HERV-E4-1 loci by cloning and sequencing revealed six HERV-E4-1 proviral loci that are differentially regulated in urothelial carcinoma cells and normal tissue. Two full-length HERV-E4-1 proviruses, HERV-Ec1 and HERV-Ec6, are located in antisense orientation in introns of the genes PLA2G4A and RNGTT, respectively. PLA2G4A encodes a cytosolic phospholipase A2 (cPLA2) that is dysregulated in many human tumors. PLA2G4A and HERV-Ec1 displayed reciprocal transcript levels in 7 of 11 urothelial carcinoma patients. Moreover, reciprocal shifts were observed after treatment of UROtsa cells with HERV-Ec1 and PLA2G4A-directed siRNAs or 5-aza-2′-deoxycytidine (aza-dC) pointing to an antagonistic regulation of PLA2G4A and HERV-Ec1 transcription in human urothelial cells. We suggest that transcription of HERV-Ec1 contributes to fine tuning of cPLA2 expression, thereby facilitating tumorigenesis. Public Library of Science 2012-11-07 /pmc/articles/PMC3492278/ /pubmed/23145155 http://dx.doi.org/10.1371/journal.pone.0049341 Text en © 2012 Gosenca et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gosenca, Darko Gabriel, Ute Steidler, Annette Mayer, Jens Diem, Olivia Erben, Philipp Fabarius, Alice Leib-Mösch, Christine Hofmann, Wolf-Karsten Seifarth, Wolfgang HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma |
title | HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma |
title_full | HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma |
title_fullStr | HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma |
title_full_unstemmed | HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma |
title_short | HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma |
title_sort | herv-e-mediated modulation of pla2g4a transcription in urothelial carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492278/ https://www.ncbi.nlm.nih.gov/pubmed/23145155 http://dx.doi.org/10.1371/journal.pone.0049341 |
work_keys_str_mv | AT gosencadarko hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT gabrielute hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT steidlerannette hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT mayerjens hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT diemolivia hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT erbenphilipp hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT fabariusalice hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT leibmoschchristine hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT hofmannwolfkarsten hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma AT seifarthwolfgang hervemediatedmodulationofpla2g4atranscriptioninurothelialcarcinoma |